2009
DOI: 10.1016/s0140-6736(09)61038-2
|View full text |Cite
|
Sign up to set email alerts
|

Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

12
234
0
25

Year Published

2011
2011
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 292 publications
(288 citation statements)
references
References 30 publications
12
234
0
25
Order By: Relevance
“…8 4 -8 7 High-risk patients were defined differently among the RCTs: 1) age greater than 65 years, cardiac failure as the cause of intubation or Acute Physiology and Chronic Health Evaluation (APACHE) II score greater than 12 at the time of extubation; 84 2) more than one of the following: failure of consecutive weaning trials, chronic cardiac failure, arterial pressure of carbon dioxide greater than 45 mm Hg after extubation, more than one noncardiac comorbidity, weak cough or stridor after extubation not requiring immediate intubation; 85 3) acute exacerbation of COPD 86 or 4) history of chronic respiratory disease with ventilation for more than 48 hours and hypercapnia during the spontaneous breathing trial. 87 Although the four trials defined higher risk differently, they reported consistent decreases in rates of reintubation (RR 0.42, 95% CI 0.25-0.70) and ICU mortality (RR 0.35, 95% CI 0.16-0.78) but less benefit in terms of hospital mortality (RR 0.66, 95% CI 0.42-1.04).…”
Section: After Planned Extubationmentioning
confidence: 91%
“…8 4 -8 7 High-risk patients were defined differently among the RCTs: 1) age greater than 65 years, cardiac failure as the cause of intubation or Acute Physiology and Chronic Health Evaluation (APACHE) II score greater than 12 at the time of extubation; 84 2) more than one of the following: failure of consecutive weaning trials, chronic cardiac failure, arterial pressure of carbon dioxide greater than 45 mm Hg after extubation, more than one noncardiac comorbidity, weak cough or stridor after extubation not requiring immediate intubation; 85 3) acute exacerbation of COPD 86 or 4) history of chronic respiratory disease with ventilation for more than 48 hours and hypercapnia during the spontaneous breathing trial. 87 Although the four trials defined higher risk differently, they reported consistent decreases in rates of reintubation (RR 0.42, 95% CI 0.25-0.70) and ICU mortality (RR 0.35, 95% CI 0.16-0.78) but less benefit in terms of hospital mortality (RR 0.66, 95% CI 0.42-1.04).…”
Section: After Planned Extubationmentioning
confidence: 91%
“…A subgroup analysis in one of these studies found in improvement in survival only in patients with hypercapnia during the spontaneous breathing trial (77). After these findings, the same group conducted a new RCT specifically in patients with chronic respiratory disorders and hypercapnia during a successful spontaneous breathing trial, with the same study design (78). The results from this study confirm again that the use of NIV immediately after extubation results in decreased incidence of respiratory failure after extubation and improved survival.…”
Section: © C I C E D I Z I O N I I N T E R N a Z I O N A L Imentioning
confidence: 55%
“…Both studies showed that the groups treated with NIV had a lower re-intubation rate and a lower ICU mortality than the groups treated with standard therapy. Furthermore, one study [36] found a better 90-days survival in a subgroup of hypercapnic patients treated with NIV. To confirm the result found in this subgroup of patients, Ferrer and colleagues [36] performed a multi-centre randomized controlled trial specifically designed for patients who developed hypercapnia during an SBT.…”
Section: Niv and Post-extubation Failure Preventionmentioning
confidence: 98%